Tenpoint Therapeutics, Ltd. has announced the appointment of Stephen S. Lane, M.D., as Chief Medical Officer (CMO).
A world-renowned ophthalmologist, Dr. Lane brings 40 years of ophthalmology leadership experience in clinical practice and the pharmaceutical industry, most recently serving as Chief Medical Officer and Head of Medical Safety at Alcon. He is the past-President of the ASCRS, a former member of the Committee of Secretaries at the American Academy of Ophthalmology (AAO), a former Board Member and Officer of the International Society of Refractive Surgery (ISRS), and a Board Member of the Minnesota Academy of Ophthalmology.
“Dr. Lane is a highly respected ophthalmology leader whose experience spans clinical practice, product development, and medical leadership at the highest levels of the industry,” said Henric Bjarke, Chief Executive Officer of Tenpoint Therapeutics. “He is exceptionally well suited to help drive Tenpoint Therapeutics as we advance innovative therapies for the aging eye and enter this next stage of commercial growth.”
Dr. Lane commented: “I am excited to join Tenpoint Therapeutics at a time of significant opportunity for the company and the field of ophthalmology. [The company's] dedication to advancing innovative treatments for the aging eye aligns closely with my passion for improving patient outcomes. I look forward to working with the team to further develop and deliver solutions that address the unmet needs of both patients and the eye care professionals who care for them.”
